Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
Cabergoline Side Effects: Common, Severe, Long Term - Drugs.com
Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated | SpringerLink
Cabergoline monotherapy in the long-term treatment of Cushing's disease in: European Journal of Endocrinology Volume 163 Issue 5 (2010)
Does Cabergoline Help in Decreasing Chronic Pelvic Pain Due to Endometriosis Compared to Medroxyprogesterone Acetate? A Prospect
Cabergoline - Wikipedia
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia | NEJM
Cabergoline - Side Effects, Dosage, Precautions, Uses
Long term management of prolactinoma
PDF) Cabergoline-induced manic episode: case report | N. Dilbaz - Academia.edu
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia | NEJM
Cabergoline For Men — Subjects and Methods
Dostinex Side Effects: Common, Severe, Long Term - Drugs.com
PDF) Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
CABERGOLINE A dopamine agonist for the treatment of ADVANCED Parkinson's disease TRADE NAME: Cabaser® MANUFACTURER: Pharmacia
Cabergoline-induced manic episode: case report
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia | NEJM
Dostinex 0.5 mg Tablet 2pcs
Cabergoline: Package Insert / Prescribing Information - Drugs.com
Side effects observed with cabergoline in the two groups | Download Table
Society for Endocrinology
A Simple Guide to Dostinex (Cabergoline) for Hyperprolactinemia
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM
Cabergoline: Learn About Cabergoline Uses, Dosage, Side-Effects, Warnings on PharmEasy
